{"id":1265,"date":"2022-07-27T14:37:11","date_gmt":"2022-07-27T05:37:11","guid":{"rendered":"https:\/\/fgb.tamagawa-seiki.com\/english\/?post_type=technology&#038;p=1265"},"modified":"2022-08-24T15:15:29","modified_gmt":"2022-08-24T06:15:29","slug":"iwamoto-et-al-2018-2","status":"publish","type":"technology","link":"https:\/\/fgb.tamagawa-seiki.com\/english\/technology\/iwamoto-et-al-2018-2","title":{"rendered":"Iwamoto et al.(2018) [nSMOL]"},"content":{"rendered":"<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29968534\/\" target=\"_blank\" rel=\"noopener noreferrer\">Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum<\/a><br \/>\nCurrent Pharmaceutical Biotechnology, 2018, 19, 495-505<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","acf":[],"_links":{"self":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/technology\/1265"}],"collection":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/technology"}],"about":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/types\/technology"}],"wp:attachment":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/media?parent=1265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}